Pattern of retroperitoneal dissemination of primary peritoneum cancer: Basis for rational use of lymphadenectomy

Gynecologic Oncology

Volumn 114, Issue 1, 2009, Pages 32-36

  Aletti, Giovanni D ^a   Powless, Cecelia ^a   Bakkum Gamez, Jamie ^a   Wilson, Timothy O ^a   Podratz, Karl C ^a   Cliby, William A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Lymphadenectomy; Lymphatic dissemination; Ovarian carcinoma; Primary peritoneal carcinoma; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MINIMAL RESIDUAL DISEASE; OVERALL SURVIVAL; PARAAORTIC LYMPH NODE; PELVIS LYMPH NODE; PERITONEUM CANCER; PRIORITY JOURNAL; PROGNOSIS; RETROPERITONEAL CANCER; SURVIVAL TIME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ASCITES; FEMALE; HUMANS; LYMPH NODE EXCISION; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; RETROPERITONEAL NEOPLASMS; SURVIVAL RATE; SURVIVORS;

EID: 67349090631     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.03.020     Document Type: Article

References (33)

1. Swerdlow M. Mesothelioma of the pelvic peritoneum resembling papillary cystadenocarcinoma of the ovary; case report. Am. J. Obstet. Gynecol. 77 (1959) 197-200
2. Lele S.B., Piver M.S., Matharu J., and Tsukada Y. Peritoneal papillary carcinoma. Gynecol. Oncol. 31 (1988) 315-320
3. Bloss J.D., Liao S.Y., Buller R.E., et al. Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary. Gynecol. Oncol. 50 (1993) 347-351
4. Eltabbakh G.H., Piver M.S., Natarajan N., et al. Epidemiological differences between women with extra-ovarian primary peritoneal carcinoma and women with epithelial ovarian cancer. Obstet. Gynecol. 91 (1998) 254-259
5. Eltabbakh G.H., and Piver M.S. Extraovarian primary peritoneal carcinoma. Oncology (Williston. Park) 12 (1998) 813-819 discussion 20, 25-6
6. Piek J.M., Kenemans P., and Verheijen R.H. Intraperitoneal serous adenocarcinoma: a critical appraisal of three hypotheses on its cause. Am. J. Obstet. Gynecol. 191 3 (2004) 718-732 Review
7. Hamilton T.C. Ovarian cancer, part I: biology. Curr. Probl. Cancer. 16 (1992) 1-57
8. Feeley K.M., and Wells M. Precursor lesions of ovarian epithelial malignancy. Histopathology 38 (2001) 87-95
9. Fenoglio C.M., Castadot M.J., Ferenczy A., Cottral G.A., and Richart R.M. Serous tumors of the ovary: I, ultrastructural and histochemical studies of the epithelium of the benign serous neoplasms, serous cystadenoma and serous cystadenofibroma. Gynecol. Oncol. 5 (1977) 203-218
10. Finch A., Shaw P., Rosen B., et al. Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers. Gynecol. Oncol. 100 (2006) 58-64
11. Callahan M.J., Crum C.P., Medeiros F., et al. Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J. Clin. Oncol. 25 (2007) 3985-3990
12. Carlson J.W., Miron A., Jarboe E.A., et al. Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention. J. Clin. Oncol. 1 26(25) (2008) 4160-4165
13. Dubeau L. The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes?. Gynecol. Oncol. 72 (1999) 437-442
14. Tong G.X., Chiriboga L., Hamele-Bena D., et al. Expression of PAX2 in papillary serous carcinoma of the ovary: immunohistochemical evidence of fallopian tube or secondary Müllerian system origin?. Mod. Pathol. 20 (2007) 856-863
15. Chen S.S., and Lee L. Incidence of para-aortic and pelvic lymph node metastases in epithelial carcinoma of the ovary. Gynecol. Oncol. 16 (1983) 95-100
16. Morice P., Joulie F., Camatte S., et al. Lymphnode involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications. J. Am. Coll. Surg. 197 (2003) 198-205
17. Burghardt E., Girardi F., Lahousen M., et al. Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer. Gynecol. Oncol. 40 (1991) 103-106
18. Benedetti-Panici P., Greggi S., Maneschi F., et al. Anatomical and pathological study of retroperitoneal nodes in epithelial ovarian cancer. Gynecol. Oncol. 51 (1993) 150-154
19. Aletti G.D., Dowdy S., Podratz K.C., and Cliby W.A. Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer. Am. J. Obstet. Gynecol. 196 6 (2006) 1862-1868
20. Onda T., Yoshikawa H., Yokota H., et al. Assessment of metastases to aortic and pelvic lymphnodes in epithelial ovarian carcinoma: a proposal for essential sites for lymphnode biopsy. Cancer 78 (1996) 803-808
21. Dalrymple J.C., Bannatyne P., Russell P., et al. Extraovarian peritoneal serous papillary carcinoma. A clinicopathologic study of 31 cases. Cancer 64 (1989) 110-115
22. Eltabbakh G.H., and Mount S.L. Lymphatic spread among women with primary peritoneal carcinoma. J. Surg. Oncol. 81 3 (2002) 126-131
23. Dubernard G., Morice P., Rey A., Camatte S., Pautier P., Lhommé C., Duvillard P., and Castaigne D. Lymph node spread in stage III or IV primary peritoneal serous papillary carcinoma. Gynecol. Oncol. 97 1 (2005 Apr) 136-141
24. Cancer Committee of the International Federation of Gynecology and Obstetrics. Staging announcement: FIGO Cancer Committee. Gynecol. Oncol. 25 (1986) 383
25. Eisenhauer E.L., Sonoda Y., Levine D.A., et al. Platinum resistance and impaired survival in patients with advanced primary peritoneal carcinoma: matched-case comparison with patients with epithelial ovarian carcinoma. Am. J. Obstet. Gynecol. 198 2 (2008) 213 e1-7
26. Fromm G.L., Gershenson D.M., and Silva E.G. Papillary serous carcinoma of the peritoneum. Obstet. Gynecol. 75 (1990) 89-95
27. Piver M.S., Eltabbakh G.H., Hempling R.E., Recio F.O., and Blumenson L.E. Two sequential studies for primary peritoneal carcinoma: induction with weekly cisplatin followed by either cisplatin-doxorubicin-cyclophosphamide or paclitaxel-cisplatin. Gynecol. Oncol. 67 (1997) 141-146
28. Eltabbakh G.H., Werness B.A., Piver S., and Blumenson L.E. Prognostic factors in extraovarian primary peritoneal carcinoma. Gynecol. Oncol. 71 (1998) 230-239
29. Eisenkop S.M., and Spirtos N.M. The clinical significance of occult macroscopically positive retroperitoneal nodes in patients with epithelial ovarian cancer. Gynecol. Oncol. 82 1 (2001) 143-149
30. Morice P., Joulie F., Camatte S., et al. Lymphnode involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications. J. Am. Coll. Surg. 197 (2003) 198-205
31. Chan J.K., Urban R., Hu J.M., et al. The potential therapeutic role of lymphnode resection in epithelial ovarian cancer: a study of 13918 patients. Br. J. Cancer. 96 (2007) 1817-1822
32. Pereira A., Magrina J.F., Rey V., et al. Pelvic and aortic lymphnode metastasis in epithelial ovarian cancer. Gynecol. Oncol. 105 (2007) 604-608
33. Benedetti Panici P., Maggioni A., Hacker N., et al. Systematic aortic and pelvic lymphadenectomy vs resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomised clinical trial. J. Natl. Cancer. Inst. 97 (2005) 560-566